As treatment continues and the dose increases, many patients report stronger hunger regulation and better control over eating habits
FAQ Semaglutide has been thoroughly studied and is approved for long-term use
Indications and Limitations of Use Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes mellitus and established CV disease
The results showed 20.7 percent weight loss with the higher dose versus 17.5 percent with 2.4 mg
Alexander Shapsis, MD, FACS EndoSlim Clinic NY Contents show Ozempic and Wegovy can support meaningful weight loss, but nausea, constipation, diarrhea, vomiting, heartburn, and abdominal discomfort can make treatment difficult for some patients
Abstract/Full Text (subscription or payment may be required)